Search results
Results from the WOW.Com Content Network
Aharonson-Daniel is a member of the CDCs' International Collaborative Effort (ICE) on injury statistics, [10] core member of the Global Burden of Disease study 'Injuries Expert Group', [11] the Society for the Advancement of Violence and Injury Research (SAVIR), the World Association of Disaster and Emergency Medicine (WADEM) where she served ...
Disease burden is the impact of a health problem as measured by financial cost, mortality, morbidity, or other indicators. It is often quantified in terms of quality- ...
The Global Burden of Disease Study began in 1990 as a single World Bank–commissioned [3] study that quantified the health effects of more than 100 diseases and injuries for eight regions of the world, giving estimates of morbidity and mortality by age, sex, and region.
Since 1980, the U.S. Centers for Disease Control and Prevention has been organized around constituent centers, institutes, and offices (CIOs). Five centers were created in 1980, which was reflected in CDC's contemporaneous name change from the singular "Center" to plural "Centers".
Disability-adjusted life years (DALYs) are a measure of overall disease burden, expressed as the number of years lost due to ill-health, disability, or early death.It was developed in the 1990s as a way of comparing the overall health and life expectancy of different countries.
Human infectious diseases may be characterized by their case fatality rate (CFR), the proportion of people diagnosed with a disease who die from it (cf. mortality rate).It should not be confused with the infection fatality rate (IFR), the estimated proportion of people infected by a disease-causing agent, including asymptomatic and undiagnosed infections, who die from the disease.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
A more macro-level analysis from the Global Burden of Disease data conducted by Murray and others (2015) finds that while there is a global trend towards decreasing mortality and increasing NCD prevalence, this global trend is being driven by country-specific effects as opposed to a broader transition; further, there are varying patterns within ...